Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra.

【書誌情報】

ページ数：4ページ

サイズ：A4

商品番号：HBSP-506062

発行日：2006/2/23

登録日：2010/11/17